GSK nears $1bn deal for biotech developing drug for rare tumour
- Posted on January 8, 2025
- By Financial Times
- 2 Views
GSK nears $1bn deal for biotech developing drug for rare tumour
IDRx tests treatment for digestive system cancer that affects 4,000 to 6,000 people a year in US
